Loading the section
Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Pacific Biosciences of California, Inc. trades on Nasdaq under the ticker PACB. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PACB has traded between 1.07 $ and 3.44 $. As of 09 October 2026 the price stood 53.16 % of the way from the 52-week low to the high.
Over one year PACB shares rose 54.30 %; over six months they rose 73.88 %. Volatility over 90 days is 96.84 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 4.4, above the sector median of 3.9. Price to book is 296, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 2.35 | 2.47 | 2.21 | 2.33 | 13M |
| 08 October 2026 | 2.63 | 2.69 | 2.22 | 2.30 | 24M |
| 07 October 2026 | 2.62 | 2.74 | 2.50 | 2.72 | 20M |
| 06 October 2026 | 3.02 | 3.44 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Pacific Biosciences of California, Inc. (PACB) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 160.0m $, net income was -546.4m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025, US
Pacific Biosciences of California, Inc. reported revenue of 160M $ and a net loss of 129M $ over the last four quarters. Net margin is −80.34 %. Revenue changed by +5.04 % year over year. Earnings per share are −0.41 $. Market capitalisation is 700M $.
| 303M |
| MTDMettler-Toledo International, Inc. | 1,550 | +1.34 % | 295M |
| TXG10x Genomics, Inc. | 80.65 | +4.36 % | 269M |
| BRKRBruker Corporation | 59.00 | +1.86 % | 137M |
| AVTRAvantor, Inc. | 15.67 | +1.82 % | 130M |
| 2.43 |
| 2.70 |
| 47M |
| 05 October 2026 | 2.53 | 2.92 | 2.51 | 2.87 | 26M |
| 02 October 2026 | 2.50 | 2.65 | 2.44 | 2.54 | 26M |
| 01 October 2026 | 2.34 | 2.56 | 2.32 | 2.51 | 36M |
| 30 September 2026 | 1.84 | 2.46 | 1.84 | 2.37 | 80M |
| 29 September 2026 | 1.68 | 1.85 | 1.63 | 1.83 | 17M |
| 28 September 2026 | 1.60 | 1.80 | 1.59 | 1.71 | 21M |
| 25 September 2026 | 1.57 | 1.63 | 1.52 | 1.62 | 11M |
| 24 September 2026 | 1.40 | 1.59 | 1.38 | 1.58 | 11M |
| 23 September 2026 | 1.45 | 1.47 | 1.39 | 1.41 | 5M |
| 22 September 2026 | 1.38 | 1.48 | 1.36 | 1.47 | 8M |
| 21 September 2026 | 1.37 | 1.40 | 1.34 | 1.36 | 6M |
| 18 September 2026 | 1.38 | 1.40 | 1.34 | 1.37 | 5M |
| 17 September 2026 | 1.37 | 1.43 | 1.36 | 1.38 | 6M |
| 16 September 2026 | 1.34 | 1.40 | 1.32 | 1.34 | 5M |
| 15 September 2026 | 1.36 | 1.41 | 1.34 | 1.34 | 6M |
| 14 September 2026 | 1.28 | 1.38 | 1.28 | 1.35 | 5M |